<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05018468</url>
  </required_header>
  <id_info>
    <org_study_id>IR.MUI.REC.1395.3.424</org_study_id>
    <nct_id>NCT05018468</nct_id>
  </id_info>
  <brief_title>Quality of Ventilation With Facial Versus Nasal Mask vs Nasal Mask Anesthesia in Children 3 to 12 Years Old</brief_title>
  <official_title>Evaluation of the Quality of Ventilation With Facial Versus Nasal Mask After Induction of Anesthesia in Children 3 to 12 Years Old</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Isfahan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Isfahan University of Medical Sciences</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this single-blind clinical trial study, 70children who are candidates for lower abdominal&#xD;
      elective surgery under general anesthesia presented at Imam Hossein Hospital in Isfahan will&#xD;
      be included in the study and will be divided into 2 groups. In the first group, ventilation&#xD;
      with facial mask and in the second group, ventilation with nasal mask will be done for three&#xD;
      minutes. Then the reduction in SPO2 and the impossibility of ventilation of patients will be&#xD;
      evaluated and compared between the two groups.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Actual">June 20, 2021</completion_date>
  <primary_completion_date type="Actual">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average airway pressure</measure>
    <time_frame>change from baseline at five minutes after incubation</time_frame>
    <description>Ventilation device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Average End-tidal CO2 (EtCO2)</measure>
    <time_frame>change from baseline at five minutes after incubation</time_frame>
    <description>Ventilation device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Average Oxygen saturation (SpO2)</measure>
    <time_frame>change from baseline at five minutes after incubation</time_frame>
    <description>Ventilation device</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Ventilation</condition>
  <condition>Intubation Complication</condition>
  <condition>Intubation; Difficult or Failed</condition>
  <arm_group>
    <arm_group_label>ventilation with an anatomical facial mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention group 1: Patients in this group undergo ventilation with an anatomical facial mask and 100% oxygen for three minutes. Intervention group 2: Patients in this group undergo ventilation with a nasal mask and 100% oxygen for three minutes. In both groups, ventilation will be performed with the controlled mode of the anesthesia machine with a volume of 8 cc/kg and a speed of 12-20/min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ventilation with a nasal mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention group 2: Patients in this group undergo ventilation with a nasal mask and 100% oxygen for three minutes. Ventilation will be performed with the controlled mode of the anesthesia machine with a volume of 8 cc/kg and a speed of 12-20/min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ventilation</intervention_name>
    <description>Patients in group 1 undergo ventilation with an anatomical facial mask and 100% oxygen for three minutes. Patients in group 2 undergo ventilation with a nasal mask and 100% oxygen for three minutes. In both groups, ventilation will be performed with the controlled mode of the anesthesia machine with a volume of 8 cc/kg and a speed of 12-20/min.</description>
    <arm_group_label>ventilation with a nasal mask</arm_group_label>
    <arm_group_label>ventilation with an anatomical facial mask</arm_group_label>
    <other_name>Mask</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age category between 3 to 12 years&#xD;
&#xD;
          -  Candidate for lower abdominal elective surgery under general anesthesia&#xD;
&#xD;
          -  No obstruction in the nasal pathway&#xD;
&#xD;
          -  No deformity and fractures in facial&#xD;
&#xD;
          -  No acute or chronic lung disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Impossibility of airway oropharyngeal ventilation&#xD;
&#xD;
          -  Impossibility of ventilation of the anatomical facial mask with neck extension&#xD;
&#xD;
          -  Dissatisfaction with participating in the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Alzahra Hospital</name>
      <address>
        <city>Isfahan</city>
        <zip>8195163381</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 1, 2021</study_first_submitted>
  <study_first_submitted_qc>August 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2021</study_first_posted>
  <last_update_submitted>August 20, 2021</last_update_submitted>
  <last_update_submitted_qc>August 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Isfahan University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Amir Shafa</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

